Key Record Dates
ClinicalTrials.gov Identifier: | NCT05519085 |
---|---|
Brief Title: | A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (SUCCESSOR-1) |
First Submitted : | August 25, 2022 |
First Submitted that Met QC Criteria : | August 25, 2022 |
First Posted : | August 29, 2022 |
Last Update Submitted that Met QC Criteria : | May 2, 2024 |
Last Update Posted : | May 3, 2024 |